Insights on Clinical Trials

31. How CROs, Sites, PIs, And Sponsors Work Better Together 11/7/2025

    Each role is critical, yet operating in isolation results in slower timelines, duplicated effort, and missed opportunities. When collaboration replaces coordination, trials gain speed, quality, and patient trust.

32. Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025) 11/7/2025

    Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.

33. How Emerging Technologies Are Challenging Traditional IRB Oversight 11/6/2025

    Uncover how sponsors, CROs, and study monitors can navigate FDA expectations and Institutional Review Board (IRB) requirements when integrating AI and Software-as-a-Medical-Device into clinical trials.

34. Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/5/2025

    Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.

35. Tips For Partnering With Health Systems: A Critical Step For CGT Commercialization 11/3/2025

    Collaborating with health systems is key to CGT commercialization. Learn how to address operational and financial challenges to ensure processes are scalable and patient access is streamlined.

36. Maintaining Compliance In Gene Therapy Trials For Neurological Conditions 10/29/2025

    To identify efficacious treatments for neurological conditions, drug sponsors must design ethical clinical trials that protect participants and caregivers while ensuring compliance with regulators.

37. Bridging The Trust Gap: How Patient Advocacy Groups Transforms Trial Recruitment 10/27/2025

    Explore how collaboration between researchers and Patient Advocacy Groups (PAGs) can bridge the trust gap that undermines recruitment and can make trial participation more approachable and meaningful.

38. The Immunotherapy Revolution's Path To Precision 10/27/2025

    Learn how comprehensive immune profiling and translational models can illuminate these mechanisms, inform dose selection, and guide the next generation of immunotherapies toward safer, more targeted innovation.

39. Using AI Tools In Hepatology Drug Development 10/27/2025

    Explore how AI can help overcome key challenges in hepatology trials — from site selection and patient matching to data integration and engagement — while ensuring diversity, privacy, and transparency.

40. The Evolving RNA Landscape: Navigating Science, Strategy, And Global Markets 10/27/2025

    Learn how to streamline development, reduce costs, and accelerate the path to market for next-generation RNA therapies.